ClinicalTrials.gg
CompletedNCT00711672Updated Jun 3, 2015

Study of the Therapeutic Use of Language in Patients With Metastatic Colorectal Cancer

An observational study in Colorectal Cancer, sponsored by Hematology and Oncology Associates of NE Pennsylvania. Completed at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-06-03.

Sponsored by Hematology and Oncology Associates of NE Pennsylvania · Observational

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
5
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 2,342 studies in Colorectal Neoplasms with a site in United States — 415 open to participants now, 629 under way, 30 of them phase 3. Colorectal Neoplasms · United States.

Enrollment
313th of 325
5 · median 220
Started
2008
with 71 others
Observational
326 of 2,342
68 open now
Registered
509th of 2,342
by date

Among the 2,342 studies in Colorectal Neoplasms with a site in United States, this one is the 313th largest by enrollment of the 325 observational ones that give a count, is one of 72 that started in 2008, is one of 326 observational ones, and was the 509th registered.

Colorectal Neoplasms

6,556 studies on the registry are indexed under Colorectal Neoplasms; 1,664 are open to participants now.

Browse Colorectal Neoplasms studies →

Open to participants now

415 of the 2,342 studies in Colorectal Neoplasms with a site in United States are open now. Recruiting first, the newest first:

410 more — sign in →

All 415 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 1,179 Colorectal Neoplasms studies recruiting now, 762 (65%) set no upper age limit and 264 (22%) stop at 75 or younger; 48 take children under 18; 123 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 2,342 studies in Colorectal Neoplasms with a site in United States, or all of them as a file.
02

Study summary

The purpose of this study is to determine if the degree of agreement between patients and their physicians regarding the "story" of the illness correlates with improved patient symptom control and quality of life. Another goal of the study is to examine the actual language used by patients and physicians in a specific clinical situation.

Read the detailed description

The purpose of this study is to investigate the co-created therapeutic narrative in scheduled office visits between adult patients with metastatic colorectal carcinoma and their medical oncologists in a community practice setting. The study will focus on the negotiation of the illness narrative and the semiotic (primarily linguistic) tools employed. The study will involve patients from a large community cancer center from Northeastern Pennsylvania (this center sees about 3,000 new patients each year). About 85% of patients with cancer in the United States are treated in this type of setting (National Cancer Institute, 2007), and so many results from this population are applicable to most cancer patients in the United States. The location of this study makes it very different from the majority of medical anthropological studies that are usually performed in urban academic medical centers or in sites outside of the United States or Western Europe. Although community cancer centers are the location of most of the treatment of patients with cancer in the United States, there are few to no studies published studying this patient population.

03

Conditions studied

  • Colorectal Cancer

Keywords

  • Personal Communication
  • Doctor Patient Relations
  • Narrative Medicine
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients with metastatic colorectal carcinoma and their physicians at a large community cancer center in Northeastern Pennsylvania.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients and Physicians at Hematology and Oncology Associates of NE Pennsylvania
  • Patients must have (stage IV) colorectal carcinoma
  • Patients must be on treatment for their disease
  • Patients must be scheduled for re-staging CT scans
  • Patients must be older than 18 years old

Exclusion criteria

Exclusion Criteria:

  • Patients with a diagnosis other than colorectal carcinoma
  • Patients not receiving active treatment or not having re-staging CT scans
  • Patients younger than 18 years old
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Metastases

Cancer that has spread from where it began to other parts of the body. “Metastatic” cancer is cancer that has spread this way.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
5 participants (actual)

Groups and cohorts

  • 1

    Medical Oncologists treating patients with metastatic colorectal cancer

  • 2

    Patients with metastatic colorectal cancer receiving re-staging CT scans

06

What researchers measure

Primary outcomes

  1. Correlation of degree of "narrative agreement" with validated quality of life measures

    Time frame: 6-8 weeks

07

Study locations

1 site
  • Hematology and Oncology Associates of Northeastern Pennsylvania, PC
    Dunmore, Pennsylvania 18512, United States
08

References and documents

Publications

  • Agha, A. (2007). Language and Social Relations. Studies in the Social and Cultural Foundations of Language. Cambridge, Cambridge University Press. 24: 242-244.
  • Ainsworth-Vaughn, N. (1998). Claiming Power in Doctor-Patient Talk. New York, Oxford University Press.
  • Austin, J.L. (1975) How to do things with Words. Ed. J.O. Urmson and Marina Sbisa. Cambridge, MA, Harvard University Press.
  • Briggs, C. (1986) Learning How to Ask:A sociolinguistic appraisal of the role of the interview in social science research. Cambridge, Cambridge University Press.
  • Cassel EJ. The nature of suffering and the goals of medicine. N Engl J Med. 1982 Mar 18;306(11):639-45. doi: 10.1056/NEJM198203183061104. PubMed 7057823 ↗
  • Cassell, E. J. (1991). The Nature of Suffering and the Goals of Medicine. New York, Oxford University Press: 37-43.
  • Charon, R. (2006). Narrative Medicine: Honoring the Stories of Illness. New York, Oxford.
  • Csordas, T. J. ed. (1994). Embodiment and experience: The existential ground of culture and self. Cambridge Studies in Medical Anthropology. Cambridge: Cambridge University Press.
  • Gee, J.P. (2005) An Introduction to Discourse Analysis: Theory and Method, 2nd ed. New York, Routledge.
  • Eggly S. Physician-patient co-construction of illness narratives in the medical interview. Health Commun. 2002;14(3):339-60. doi: 10.1207/S15327027HC1403_3. PubMed 12186492 ↗
  • Ferrell BR, Dow KH, Grant M. Measurement of the quality of life in cancer survivors. Qual Life Res. 1995 Dec;4(6):523-31. doi: 10.1007/BF00634747. PubMed 8556012 ↗
  • Foucault, M. (1994). The Birth of the Clinic: An Archaeology of Medical Perception. New York, NY, Vintage Books.
  • Frank, A. W. (1995). The Wounded Storyteller: Body, Illness, and Ethics. Chicago, Chicago University Press.
  • Goffman, E. (1963) Stigma: Notes on the Management of Spoiled Identity. Englewood Cliffs, Prentice Hall.
  • Good, B. J. (1994). Medicine, Rationality, and Experience: an anthropological perspective. Cambridge, Cambridge University Press.
  • Laderman, C. and M, Roseman eds (1996) The Performance of Healing. London, Routledge.
  • Linde, C. (1993) Life Stories: The Creation of Coherence. New York, Oxford University Press.
  • Lock, M. and N. Scheper-Hughes (1996). A Critical-Interpretive Approach in Medical Anthropology: Rituals and Routines of Discipline and Dissent. Medical Anthropology: Contemporary Theory and Method. C. F. Sargent and T. M. Johnson. Westport, CT, Praeger Publishers: 47.
  • Lyotard, J.-F. (1984). The Postmodern Condition: A Report on Knowledge. Minneapolis, University of Minnesota Press.
  • Lortie F. Healing dramas and clinical plots: the narrative structure of experience. BMJ. 1999 May 1;318(7192):1219. doi: 10.1136/bmj.318.7192.1219. No abstract available. PubMed 10221969 ↗
  • Mehan, H. (1996). The Construction of an LD student: A case study in the politics of Representation. Natural Histories of Discourse. M. Silverstein and G. Urban. Chicago, The University of Chicago Press: 253-276.
  • Mishler, E. G. (1984). The Discourse of Medicine: Dialectics of Medical Interviews. Norwood, NJ, Ablex Publishing Corporation.
  • National Cancer Institute (2007). "NCI Community Cancer Centers Program Pilot 2007-2010." from http://ncccp.cancer.gov/Media/FactSheet.htm.
  • Riessman, Catherine Kohler. (1993) Narrative Analysis. Newbury Park, Sage University Paperback
  • Ross, N. (2004). Culture and Cognition: Implications for Theory and Method. Thousand Oaks, CA, Sage
  • Sontag, S. (2002). Illness as Metaphor and AIDS and Its Metaphors. New York, Penguin Books.
  • The University of Texas--M.D.Anderson Cancer Center. (1999) "MDASI, M.D. Anderson Symptom Inventory Core Items", University of Texas.
  • Webb, M. (1999). The Good Death: The New American Search to Reshape the End of Life. New York, Bantam.
09

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jul 2008, a primary completion of Oct 2009 and a completion of Oct 2009. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Jul 7, 2008
First posted
Jul 9, 2008
Start
Jul 2008
Primary completionActual
Oct 2009
CompletionActual
Oct 2009
Last update
Jun 3, 2015
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 3, 2015, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00711672
Lead sponsor
Hematology and Oncology Associates of NE Pennsylvania
First posted
Jul 9, 2008
Start date
Jul 2008
Primary completion
Oct 2009
Completion
Oct 2009
Last update
Jun 3, 2015

Study contacts

Christian S Adonizio, MD
principal investigator · Hematology and Oncology Associates of NE Pennsylvania

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2011. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion